At a glance
ClinicalIndex Comparison RecordN/ACompleted· 500 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transillumination for Breast Cancer Risk Assessment
In Brief
An observational study for Breast Cancer. Completed, enrolled 500 participants across 2 sites.
Detailed Summary
This study aims to evaluate if a light based technique, called Transillumination Breast Spectroscopy (TIBS), can be used to construct a non-invasive breast cancer risk predictor which provides a better odds ratio than mammographic parenchymal density.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2005
Enrollment StartJul 2006
Primary CompletionMar 2009
Study CompletionSep 2009
TodayJul 2026
First PostedSep 16, 2005
Enrollment StartJul 1, 2006
Primary CompletionMar 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 20.8 years ago